Akzo Nobel N.V.
AKZA.AS · AMS
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | €9,895,445 | €12,586,868 | €10,931,430 | €17,848,627 |
| - Cash | €1,302,000 | €1,513,000 | €1,450,000 | €1,152,000 |
| + Debt | €5,368,000 | €5,563,000 | €5,875,000 | €3,550,000 |
| Enterprise Value | €13,961,445 | €16,636,868 | €15,356,430 | €20,246,627 |
| Revenue | €10,711,000 | €10,668,000 | €10,846,000 | €9,587,000 |
| % Growth | 0.4% | -1.6% | 13.1% | – |
| Gross Profit | €4,337,000 | €4,234,000 | €3,923,000 | €3,855,000 |
| % Margin | 40.5% | 39.7% | 36.2% | 40.2% |
| EBITDA | €1,399,000 | €1,413,000 | €1,052,000 | €1,530,000 |
| % Margin | 13.1% | 13.2% | 9.7% | 16% |
| Net Income | €542,000 | €442,000 | €352,000 | €829,000 |
| % Margin | 5.1% | 4.1% | 3.2% | 8.6% |
| EPS Diluted | 3.16 | 2.58 | 2.01 | 4.46 |
| % Growth | 22.5% | 28.4% | -54.9% | – |
| Operating Cash Flow | €673,000 | €1,120,000 | €263,000 | €605,000 |
| Capital Expenditures | -€306,000 | -€286,000 | -€292,000 | -€288,000 |
| Free Cash Flow | €367,000 | €840,000 | -€29,000 | €317,000 |